ArticleCureus2026
Hyponatremia as the Initial Presentation of Rathke's Cleft Cyst-Related Hypopituitarism.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rathke's cleft cyst (RCC) is a benign sellar lesion that is frequently detected incidentally, while symptomatic cases are uncommon. Endocrine dysfunction may occur due to compression of the pituitary gland, but profound hyponatremia as the initial manifestation of RCC-related hypopituitarism is rare and may delay diagnosis. We report the case of a 76-year-old woman who presented with persistent dizziness and severe euvolemic hyponatremia. Further endocrine assessment demonstrated secondary adrenal insufficiency, central hypothyroidism, hypogonadotropic hypogonadism, and mild hyperprolactinemia. Magnetic resonance imaging revealed an RCC with mild suprasellar extension and pituitary stalk deviation. The patient was treated with hydrocortisone followed by levothyroxine, resulting in clinical improvement and normalization of sodium levels. Although transsphenoidal surgery was recommended, she declined operative management and remained clinically stable with hormone replacement therapy during six months of follow-up. This case highlights that RCC-related hypopituitarism should be considered in patients presenting with unexplained euvolemic hyponatremia, even in the absence of headache, visual disturbances, or other classical sellar symptoms. Early endocrine evaluation and pituitary imaging are essential to establish the diagnosis, initiate appropriate hormone replacement, and prevent recurrent hyponatremia and potentially life-threatening adrenal insufficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.